Back

Lowest complications and total mortality with Intra-aortic balloon pump vs Impella despite adjustment for 54 variable or hospital types in patients with cardiogenic shock

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - epidemiology, prognosis, outcome 5 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Mohammad Movahed

University of Arizona - College of Medicine, Tucson (United States of America)

7 More presentations in this session

Presentation thumbnail
Impact of multimorbidity on mortality in heart failure with mildly reduced and preserved ejection fraction
Doctor M. Yang (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
The impact of genetic testing in dilated cardiomyopathy: are we yet in the era of precision medicine?
Doctor I. Gomes Campos (Penafiel, PT)
Abstract Slides Video
Presentation thumbnail
Characteristics and treatment of contemporary real-world patients with cardiac transthyretin amyloidosis: a retrospective, multicenter, observational study
Doctor R. Nies (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Interstitial volume overload and risk of adverse clinical events in ambulatory heart failure
Doctor J. Montiel Perez (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Kidney failure risk equation and risk of kidney and cardiovascular outcomes in patients with heart failure with reduced ejection fraction: insights from PARADIGM-HF
Doctor I. Beldhuis (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - epidemiology, prognosis, outcome 5

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Extracorporeal membrane oxygenator (ECMO) has highest all cause inpatient mortality rate in comparison to intra-aortic balloon pump (IABP) or no device in cardiogenic shock
thumbnail
Congress Presentation
Safety and mid-term outcomes of impella compared to intra-aortic balloon pumping in patients who required mechanical cardiac support
thumbnail
Congress Presentation
Comparison of efficacy and safety between impella and standard care in cardiogenic shock due to acute myocardial infarction: a systematic review

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources